niacinamide has been researched along with Retinal Neovascularization in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We tested the hypothesis that recombinant human VEGF-A165b and the serine arginine protein kinase (SRPK) inhibitor, SRPIN340, which controls splicing of the VEGF-A pre-mRNA, prevent neovascularization in a rodent model of retinopathy of prematurity (ROP)." | 3.79 | SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularization in a rat model of retinopathy of prematurity. ( Bates, DO; Dick, AD; Gammons, MV; Harper, SJ, 2013) |
| " Previous reports indicate that sorafenib, an oral multikinase inhibitor, might have a beneficial effect on retinal neovascularization." | 3.76 | Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor. ( Eibl, KH; Haritoglou, C; Kampik, A; Kernt, M; Lackerbauer, CA; Liegl, RG; Neubauer, AS; Rueping, J; Ulbig, MW, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gammons, MV | 1 |
| Dick, AD | 1 |
| Harper, SJ | 1 |
| Bates, DO | 1 |
| Kernt, M | 1 |
| Liegl, RG | 1 |
| Rueping, J | 1 |
| Neubauer, AS | 1 |
| Haritoglou, C | 1 |
| Lackerbauer, CA | 1 |
| Eibl, KH | 1 |
| Ulbig, MW | 1 |
| Kampik, A | 1 |
2 other studies available for niacinamide and Retinal Neovascularization
| Article | Year |
|---|---|
SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularization in a rat model of retinopathy of prematurity.
Topics: Animals; Blotting, Western; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Ass | 2013 |
Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor.
Topics: Adult; Aged; Astrocytes; Benzenesulfonates; Cell Survival; Humans; Light; Middle Aged; Niacinamide; | 2010 |